NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/04/2025
Back to search
Official data from USPTO
NEOCHROMOSOME
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NEOCHROMOSOME
ST13
US500000098107558Class
1, 5, 40, 42
Filing
98107558
Registration
7682018
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
02/04/2025
Trademark type
Word
Nice classes
1, 5, 40, 42
Filing date
07/28/2023
Registration date
02/04/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/04/2025
Last transaction
02/04/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/01/2017
First use in commerce
07/01/2017
Drawing code
4
Owner type
03
Owner location
Long Island City, NY
Examiner
YOUNG, SKYE
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Opentrons Labworks, Inc.
Opentrons Labworks, Inc.
Representatives
Rhett V. Barney LEE & HAYES, PC
Technical classification
Nice Classes
Class 1Class 5Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicalbiochemical and biological products for use in industry and science for use in production of products used in science and research; Chemicalbiochemical and biological products for use in industry and science for use in production of commercial products; Reagents for scientific and research use; Synthetic DNA and RNAsynthetic DNA and RNA strands for use in scientific and medical research
Class 5
Biological products for medical use in DNA technologyDNA products allowing recombinant production of polypeptides and monoclonal antibodies; Reagents for medical use; Synthetic DNA and RNAsynthetic DNA and RNA strands for medical laboratory use
Class 40
Custom manufacture of biopharmaceuticals; Custom manufacture of genetically modified cells and vectors;Custom manufacture of DNA Strands
Class 42
Design of biopharmaceuticals; Design of genetically modified cells and vectors; Scientific and technological servicesresearch and design in the fields of micro-biologymolecular biology and pharmaceuticals; Industrial analysis and research services in the nature of biotechnology product and production research in the field of biological pharmaceuticals; Consultancy in the field of DNA sequencing technology; Provision of information relating to industrial engineeringknowhow on DNA sequencing
Publications
History of USPTO decisions and trademark events.
26 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/04/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/14/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/14/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/26/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/26/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/19/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/05/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/05/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/05/2024
IUAF
USE AMENDMENT FILED
10/07/2024
EISU
TEAS STATEMENT OF USE RECEIVED
10/07/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/11/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/16/2024
PUBO
PUBLISHED FOR OPPOSITION
04/16/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/27/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/09/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/09/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/09/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/09/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/23/2023
GNRT
NON-FINAL ACTION E-MAILED
12/23/2023
CNRT
NON-FINAL ACTION WRITTEN
12/23/2023
DOCK
ASSIGNED TO EXAMINER
12/23/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/29/2023
NWAP
NEW APPLICATION ENTERED
08/01/2023
Continuous trademark protection
Get notified about every new filing that threatens NEOCHROMOSOME or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.